Servier and genOway to collaborate
Servier, the largest privately owned pharmaceutical firm in France, and genomics company genOway have signed a non-exclusive, one-year renewable multi-target deal in the field of in vivo gene validation.
genOway will apply its target validation technologies to provide Servier with predictable results on the quality of targets identified at the Institut de Recherches Servier.
genOway's techno- logical platform provides pharma- ceutical companies with rapid gene validation.